Nguyen AnhCo (CIK 0001977970)

Latest company ownership

Shares held
64,974
Last filed at
Nov 19, 2025
Confidence Score
46.3
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 17, 2025 Nov 19, 2025 Atara Biotherapeutics, Inc. CEO Sell 46.3 -2,915 -4.29% ✗ $38.4K
Aug 18, 2025 Aug 20, 2025 Atara Biotherapeutics, Inc. CEO Sell 46.3 -2,958 -4.18% ✗ $34.4K
May 16, 2025 May 20, 2025 Atara Biotherapeutics, Inc. CEO Sell 46.3 -3,276 -4.42% ✗ $22.2K
Mar 3, 2025 Mar 5, 2025 Atara Biotherapeutics, Inc. CEO Sell 46.3 -3,331 -4.30% ✗ $23.3K
Nov 18, 2024 Nov 20, 2024 Atara Biotherapeutics, Inc. CEO Sell 46.3 -1,664 -2.10% ✗ $18.6K
Aug 16, 2024 Aug 20, 2024 Atara Biotherapeutics, Inc. EVP, Chief Sci. & Tech Officer Sell 46.3 -1,821 -5.07% ✗ $12.1K
May 16, 2024 May 20, 2024 Atara Biotherapeutics, Inc. EVP, Chief Sci. & Tech Officer Sell 46.3 -42,899 -4.56% ✗ $26.5K
Mar 4, 2024 Mar 6, 2024 Atara Biotherapeutics, Inc. EVP, Chief Sci. & Tech Officer Sell 47.5 -10,746 -1.13% ✗ $7.7K
Nov 16, 2023 Nov 20, 2023 Atara Biotherapeutics, Inc. EVP, Chief Sci. & Tech Officer Sell 47.5 -8,856 -3.10% ✗ $3.4K
Aug 16, 2023 Aug 18, 2023 Atara Biotherapeutics, Inc. EVP, Chief Sci. & Tech Officer Sell 46.3 -15,126 -5.02% ✗ $25K